✦ LIBER ✦

PP192—Pharmacokinetics of Selexipag in Subjects with Severe Renal Impairment Compared with Healthy Subjects

✍ Scribed by Fischer, N.; Cruz, H.; Bruderer, S.; Petersen-Sylla, M.; Halabi, A.; Dingemanse, J.

Book ID: 122704814
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 35
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2013.07.222

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP194—Pharmacokinetics of Selexipag in S

PP194—Pharmacokinetics of Selexipag in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects

✍ Fischer, N.; Kaufmann, P.; Bruderer, S.; Ulč, I.; Dingemanse, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Pharmacokinetics of dolutegravir in HIV-

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

✍ Weller, Stephen; Borland, Julie; Chen, Shuguang; Johnson, Mark; Savina, Paul; Wy 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 164 KB

Pharmacokinetics of repaglinide in subje

Pharmacokinetics of repaglinide in subjects with renal impairment

✍ Marbury, T 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Pharmacokinetics of teduglutide in subje

Pharmacokinetics of teduglutide in subjects with renal impairment

✍ Rüdiger Nave, Atef Halabi, Rolf Herzog… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 254 KB

Pharmacokinetics and Safety of Ebastine

Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

✍ Dr Robert J. Noveck, Richard A. Preston, Suzanne K. Swan 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 140 KB

Pharmacokinetics of Vandetanib in Subjec

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

✍ Angelika Weil, Dr Paul Martin, Robert Smith, Stuart Oliver, Peter Langmuir, Jess 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 220 KB